Early clinical trials on use of long-acting amylin analogs as adjuncts to optimized insulin therapy in type 1 diabetes have shown reduction in HbA1c levels of 0.4-0.7 percentage point and weight loss of 3-6 kg when added to optimized insulin therapy, and the convenience of once-weekly administration is especially significant compared to the 3 times/day injections of pramlintide, which limited the use of first generation amylin analogs
Weve also explained how Glutathione compares to other skin whitening treatments in Chennai in a dedicated blog
As GLP-1 therapies expand beyond diabetes and obesity, understanding their anti-inflammatory mechanisms may unlock new therapeutic uses
Now L-Carnitine is sold as an active health supplement, which makes it far better then its previous energy drink variant
The discovery of glucagon-like peptide 1
Its approval followed extensive clinical trials demonstrating safety, bioavailability, GLP-1 receptor engagement, and meaningful weight-related outcomes
